-
401
mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
Published 2020-12-01Subjects: Get full text
Article -
402
Optimizing lipopeptide bioactivity: The impact of non-ionic surfactant dressing
Published 2024-12-01Subjects: Get full text
Article -
403
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase iii clinical t...
Published 2025-12-01Subjects: “…Varicella vaccine…”
Get full text
Article -
404
-
405
Do Activity Sensors Identify Physiological, Clinical and Behavioural Changes in Laying Hens Exposed to a Vaccine Challenge?
Published 2025-01-01Subjects: “…vaccine challenge…”
Get full text
Article -
406
Oral delivery of bovine tuberculosis vaccine to free-ranging white-tailed deer
Published 2025-02-01Subjects: Get full text
Article -
407
-
408
Hepatitis C Virus–Pediatric and Adult Perspectives in the Current Decade
Published 2024-12-01Subjects: Get full text
Article -
409
Effects of different vaccination regimes on the immunodiagnosis of tuberculosis in goats and evaluation of defined antigens
Published 2025-01-01Subjects: “…vaccines…”
Get full text
Article -
410
Optimal control of vaccine distribution in a rabies metapopulation model
Published 2008-02-01Subjects: Get full text
Article -
411
Assessment of Knowledge Gaps in Cervical Cancer Screening and HPV Vaccination Among Chinese Women: A Comprehensive Population-Based Study
Published 2025-02-01Subjects: Get full text
Article -
412
Immunogenicity and safety of a live attenuated varicella vaccine in children aged 1 to 12 years: A double-blind, randomized, parallel-controlled phase III clinical trial in China
Published 2025-12-01Subjects: “…Varicella vaccine…”
Get full text
Article -
413
-
414
A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
Published 2025-01-01Subjects: Get full text
Article -
415
A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection
Published 2025-01-01Subjects: Get full text
Article -
416
Sociodemographic factors associated with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in western Uganda
Published 2021Subjects: “…COVID-19, vaccine, Acceptance, Clinical trials, Western Uganda…”
Get full text
Article -
417
Estimating the costs of Israel’s four COVID-19 waves
Published 2023-09-01Subjects: Get full text
Article -
418
Accessibility of COVID-19 Vaccines in African Countries: A System Dynamics Model Examining Income, Logistics, and Governance
Published 2024-12-01Subjects: Get full text
Article -
419
Subthreshold coexistence of strains: the impact of vaccination and mutation
Published 2007-01-01Subjects: Get full text
Article -
420
A descriptive-multivariate analysis of community knowledge, confidence, and trust in COVID-19 clinical trials amongst Ugandans working in healthcare settings.
Published 2021Subjects: “…COVID-19 clinical trials in resource poor countries; COVID-19 vaccines; Clinical trials in Africa; COVID-19 and medical workers; vaccines, Oxford-AstraZeneca.…”
Get full text
Article